Robert Herrman - PetIQ Gen VP
| PETQDelisted Stock | USD 30.98 0.00 0.00% |
Insider
Robert Herrman is Gen VP of PetIQ Inc
| Age | 55 |
| Phone | 208 939 8900 |
| Web | https://petiq.com |
Robert Herrman Latest Insider Activity
Tracking and analyzing the buying and selling activities of Robert Herrman against PetIQ stock is an integral part of due diligence when investing in PetIQ. Robert Herrman insider activity provides valuable insight into whether PetIQ is net buyers or sellers over its current business cycle. Note, PetIQ insiders must abide by specific rules, including filing SEC forms every time they buy or sell PetIQ'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Robert Herrman over six months ago Disposition of 1402 shares by Robert Herrman of PetIQ subject to Rule 16b-3 | ||
Robert Herrman over six months ago Acquisition by Robert Herrman of 1834 shares of PetIQ subject to Rule 16b-3 |
PetIQ Management Efficiency
The company has return on total asset (ROA) of 0.0486 % which means that it generated a profit of $0.0486 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.0552 %, meaning that it created $0.0552 on every $100 dollars invested by stockholders. PetIQ's management efficiency ratios could be used to measure how well PetIQ manages its routine affairs as well as how well it operates its assets and liabilities.PetIQ Inc currently holds 468.3 M in liabilities with Debt to Equity (D/E) ratio of 1.81, which is about average as compared to similar companies. PetIQ Inc has a current ratio of 2.82, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about PetIQ's use of debt, we should always consider it together with its cash and equity.
Similar Executives
| Showing other executives | INSIDER Age | ||
| Marlo Manning | Collegium Pharmaceutical | N/A | |
| P Yugandhar | Dr Reddys Laboratories | 49 | |
| Thomas Vadaketh | Bausch Health Companies | 61 | |
| Robert Butz | Bausch Health Companies | N/A | |
| Damian Finio | Phibro Animal Health | 54 | |
| Daryl Gaugler | Pacira BioSciences, | 62 | |
| Muthusamy RPh | ANI Pharmaceuticals | 56 | |
| Anja Bosler | Evotec SE ADR | N/A | |
| Adel Mekhail | Prestige Brand Holdings | 63 | |
| Dean Siegal | Prestige Brand Holdings | N/A | |
| YatGai Au | Regencell Bioscience Holdings | 51 | |
| Jonathan MD | Pacira BioSciences, | 49 | |
| J McFarland | Zoetis Inc | 61 | |
| Abhay Nayak | Zoetis Inc | 32 | |
| D Hale | Bausch Health Companies | 34 | |
| Robert Polzer | Zoetis Inc | 55 | |
| Penny Wan | Dr Reddys Laboratories | N/A | |
| Jeff Hartness | Bausch Health Companies | N/A | |
| Tami Martin | Supernus Pharmaceuticals | 69 | |
| Deepak MBA | Dr Reddys Laboratories | 49 | |
| Keith Katkin | Emergent Biosolutions | 48 | |
Management Performance
| Return On Equity | 0.0552 | |||
| Return On Asset | 0.0486 |
PetIQ Inc Leadership Team
Elected by the shareholders, the PetIQ's board of directors comprises two types of representatives: PetIQ inside directors who are chosen from within the company, and outside directors, selected externally and held independent of PetIQ. The board's role is to monitor PetIQ's management team and ensure that shareholders' interests are well served. PetIQ's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, PetIQ's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Robert Herrman, Gen VP | ||
| Michael Smith, Executive Vice President Products | ||
| John Pearson, Executive Products | ||
| McCord Christensen, Chairman of the Board, CEO | ||
| Zvi Glasman, Chief Officer | ||
| William Carter, Executive Counsel | ||
| Jeff Caywood, Treasurer VP |
PetIQ Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is PetIQ a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0552 | |||
| Return On Asset | 0.0486 | |||
| Profit Margin | 0.01 % | |||
| Operating Margin | 0.09 % | |||
| Current Valuation | 1.3 B | |||
| Shares Outstanding | 29.67 M | |||
| Shares Owned By Insiders | 7.00 % | |||
| Shares Owned By Institutions | 93.00 % | |||
| Number Of Shares Shorted | 1.02 M | |||
| Price To Earning | 130.31 X |
Pair Trading with PetIQ
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if PetIQ position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in PetIQ will appreciate offsetting losses from the drop in the long position's value.Moving against PetIQ Stock
| 0.69 | BA | Boeing Fiscal Year End 29th of January 2025 | PairCorr |
| 0.6 | EC | Ecopetrol SA ADR | PairCorr |
| 0.59 | BKRKF | PT Bank Rakyat | PairCorr |
| 0.56 | PPERF | Bank Mandiri Persero | PairCorr |
| 0.48 | JNJ | Johnson Johnson Fiscal Year End 28th of January 2025 | PairCorr |
The ability to find closely correlated positions to PetIQ could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace PetIQ when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back PetIQ - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling PetIQ Inc to buy it.
The correlation of PetIQ is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as PetIQ moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if PetIQ Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for PetIQ can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Other Consideration for investing in PetIQ Stock
If you are still planning to invest in PetIQ Inc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the PetIQ's history and understand the potential risks before investing.
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments |